This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use. Please read our cookie policy for more information on the use of cookies on this website.
Bridging the Gap is a new webinar series focused on cell and gene therapy. Read the recap of the first session featuring Dr. Grupp, a leader in CAR T-cell therapy.
B Medical storage solutions form an integral part of the comprehensive Azenta portfolio, highlighting a shared commitment to the preservation, safe transportation, and scalable management of essent
Discover how single-cell sequencing from Azenta coupled with the data analysis platform from ROSALIND enables researchers to easily analyze scRNA-Seq data.
Learn more about the relationship between molecular mechanisms and evolution in the emergence of antimicrobial resistance. Read our expert interview with Dr. Mato Lagator.
Technologies for proteomics have lagged compared to their genomic counterparts in terms of throughput, specificity, and cost. However, Olink’s new assay is closing the gap.
Artificial DNA synthesis, a fundamental tool of synthetic biology, enables scientists to create DNA molecules of virtually any sequence without a template.